P49841 (GSK3B_HUMAN) Homo sapiens (Human)
Glycogen synthase kinase-3 beta UniProtKBInterProSTRINGInteractive Modelling
Available Structures
106 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of GSK-3/Axin complex bound to phosphorylated N-terminal auto-inhibitory pS9 pept… |
Heteromer O15169; | 100.0 | 4×GOL; 2×MG; 1×CL; 1×DTT; 1×ADP; | |||
| Crystal structure of GSK-3/Axin complex bound to phosphorylated Wnt receptor LRP6 c-motif |
Heteromer O15169; O75581; | 100 | 1×ADP; 4×GOL; 2×MG; 1×CL; | |||
| Crystal structure of GSK-3/Axin complex bound to phosphorylated Wnt receptor LRP6 e-motif |
Heteromer O15169; O75581; | 100.0 | 1×ADP; 3×GOL; 2×MG; 1×CL; 1×DTT; | |||
| Crystal structure of peptide inhibitor-free GSK-3/Axin complex |
Heteromer O15169; | 100.0 | 5×GOL; 2×MG; 1×ADP; 1×DTT; 1×CL; | |||
| BIO-2895 (BRD0705) bound GSK3beta-axin complex |
Heteromer O15169; | 100.0 | 1×6VL; | |||
| GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE |
Heteromer O15169; | 98.86 | 2×ADZ; | |||
| Identification of 2-(4-pyridyl)thienopyridinones as GSK-3beta inhibitors |
Heteromer Q92837; | 100.0 | 6×SO4; 3×GOL; 2×ZRL; | |||
| Glycogen synthase kinase-3 beta (GSK3) complex with FRATtide peptide |
Heteromer Q92837; | 100 | 2×SO4; | |||
| Glycogen Synthase Kinase 3 Beta complexed with Axin Peptide and Leucettine L4 |
Heteromer O15169; | 100 | 1×CWT; | |||
| GSK3beta complex with N-(6-(3,4-dihydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)acetamide |
Heteromer Q92837; | 100 | 3×SO4; 1×B4K; | |||
| 5-aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors |
Heteromer Q92837; | 100.0 | 3×SO4; 3×GOL; 1×SJJ; | |||
| Identification of 2-(4-pyridyl)thienopyridinones as GSK-3beta inhibitors |
Heteromer Q92837; | 100.0 | 2×SO4; 2×GOL; 1×ZRK; | |||
| Identification of 2-(4-pyridyl)thienopyridinones as GSK-3beta inhibitors |
Heteromer Q92837; | 100.0 | 6×SO4; 2×GOL; 2×ZRM; | |||
| Glycogen Synthase Kinase 3 Beta complexed with Axin Peptide and Inhibitor 7d |
Heteromer O15169; | 100 | 1×PO4; 1×UGJ; | |||
| BIO-8546 bound GSK3beta-axin complex |
Heteromer O15169; | 100.0 | 1×D1E; | |||
| Crystal structure of an activated Akt/protein kinase B (PKB-PIF chimera) ternary complex with AMP-P… |
Heteromer P31751; | 100 | 1×ANP; 2×MN; | |||
| Structure of activated form of PKB kinase domain S474D with GSK3 peptide and AMP-PNP |
Heteromer P31751; | 100 | 1×ANP; 2×MN; | |||
| STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) … |
Heteromer P31751; | 100 | 1×I5S; 1×EDO; | |||
| Spirochromane Akt Inhibitors |
Heteromer P31749; | 100 | 1×SMR; | |||
| Structure of 4-Amino-N-(4-chlorobenzyl)-1-(7H-pyrrolo(2,3-d)pyrimidin- 4-yl)piperidine-4-carboxamid… |
Heteromer P31751; | 100 | 1×X39; | |||
| Crystal Structure of Akt-1 complexed with substrate peptide and inhibitor |
Heteromer P31749; | 100 | 1×MN; 1×CQW; | |||
| STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH 4-(4-chloro-phenyl)-4-(4-(1H-pyrazol-4-yl)-phenyl)-pipe… |
Heteromer P31751; | 100 | 1×GVP; | |||
| Crystal Structure of Akt-1 complexed with substrate peptide and inhibitor |
Heteromer P31749; | 100 | 1×CQU; | |||
| Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors |
Heteromer P31751; | 100 | 1×G95; | |||
| STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH THE INHIBITOR A-443654 |
Heteromer P31751; | 100 | 1×L20; | |||
| Spirochromane Akt Inhibitors |
Heteromer P31749; | 100 | 1×SMH; | |||
| Crystal structure of AKT1 (aa 144-480) with a bisubstrate |
Heteromer P31749; | 90.0 | 1×SO4; 1×MN; | |||
| Crystal structure of Akt-1-inhibitor complexes |
Heteromer P31749; | 100 | 1×MN; 1×XFE; | |||
| Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors |
Heteromer P31751; | 100 | 1×G96; | |||
| Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitors |
Heteromer P31749; | 100 | 1×SMY; | |||
| Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors |
Heteromer P31751; | 100 | 1×G98; | |||
| Structure of 4-(4-tert-Butylbenzyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4- yl)piperidin-4-amine bound to … |
Heteromer P31751; | 100 | 1×X37; | |||
| Akt1 with AMP-PNP |
Heteromer P31749; | 100 | 1×ANP; 2×MN; | |||
| Binary complex structure of human tau protein kinase I with AMPPNP | homo-2-mer | 100 | 2×ANP; | |||
| Binary complex structure of human tau protein kinase I with ADP | homo-2-mer | 100 | 2×MG; 2×ADP; | |||
| Crystal structure of GSK3b in complex with a pyrimidylpyrrole inhibitor | homo-2-mer | 100.0 | 2×Z48; | |||
| The Crystal Structure of GSK3b from Biortus. | homo-2-mer | 100 | 2×ANP; 2×MG; 18×EDO; 3×PEG; | |||
| Crystal structure of GSK3 beta (GSK3b) in complex with CD7. | homo-2-mer | 100.0 | 2×SO4; 7×EDO; 2×O9L; | |||
| Crystal structure of GSK3 beta (GSK3b) in complex with FL291. | homo-2-mer | 100.0 | 2×SO4; 2×O9C; | |||
| GSK-3 Beta complexed with Indirubin-3'-monoxime | homo-2-mer | 100.0 | 2×IXM; | |||
| GSK-3 Beta complexed with Alsterpaullone | homo-2-mer | 100.0 | 2×ATU; | |||
| GSK-3 Beta complexed with AMP-PNP | homo-2-mer | 100.0 | 4×MG; 2×ANP; | |||
| GSK-3 Beta complexed with Inhibitor I-5 | homo-2-mer | 100.0 | 2×679; | |||
| Glycogen Synthase Kinase 3 beta. | homo-2-mer | 99.15 | 2×EPE; | |||
| GSK-3 Beta complexed with Staurosporine | homo-2-mer | 100.0 | 2×STU; | |||
| GSK3b in complex with inhibitor | homo-2-mer | 100 | 3×DMS; 2×7YG; | |||
| Extremely Tight Binding of Ruthenium Complex to Glycogen Synthase Kinase 3 | homo-2-mer | 100.0 | 2×AG1; | |||
| Crystal structure of GSK3Beta in complex with ARN25068 | homo-2-mer | 100.0 | 2×39I; 6×CL; | |||
| GSK3b in complex with inhibitor | homo-2-mer | 100 | 2×GR9; | |||
| GSK3b in complex with inhibitor | homo-2-mer | 100 | 2×6LQ; | |||
| GSK3b in complex with inhibitor | homo-2-mer | 100 | 2×KDI; | |||
| Structure of a carboxamide compound (3) (2-{2-[(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}-4-OXO-4H-1L… | homo-2-mer | 100.0 | 2×2WE; | |||
| X-RAY CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH CHIR99021 | homo-2-mer | 100.0 | 2×65C; 2×MG; 2×MES; | |||
| Structure of Ruthenium Half-Sandwich Complex Bound to Glycogen Synthase Kinase 3 | homo-2-mer | 100.0 | 2×DW1; | |||
| crystal structure of Glycogen synthase kinase 3 in complexed with inhibitor | homo-2-mer | 100.0 | 2×TMU; | |||
| Structure of a carvoxamide compound (15) (N-[4-(ISOQUINOLIN-7-YL)PYRIDIN-2-YL]CYCLOPROPANECARBOXAMI… | homo-2-mer | 100.0 | 2×2WF; | |||
| Identification of a Glycogen Synthase Kinase-3b Inhibitor that Attenuates Hyperactivity in CLOCK Mu… | homo-2-mer | 100 | 2×TSK; 2×EPE; | |||
| Glycogen synthase kinase-3 beta in complex with 3-indolyl-4-arylmaleimide inhibitor | homo-2-mer | 100.0 | 2×FLC; 2×DFN; | |||
| GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 6-BROMOINDIRUBIN-3'-OXIME | homo-2-mer | 99.43 | 2×BRW; 4×PO4; 2×CL; 2×CO; | |||
| Glycogen synthase kinase-3 beta (GSK3) complex with a covalent [1,2,4]triazolo[1,5-a][1,3,5]triazin… | homo-2-mer | 100 | 2×FKB; 1×MLI; 3×GOL; 2×CL; 1×NA; | |||
| STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 (GSK3B) | monomer | 100.0 | 2×PO4; | |||
| 3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3 | monomer | 100.0 | 1×Z92; | |||
| Crystal structure of nonphosphorylated (Tyr216) GSK3b in complex with CX-4945 | monomer | 100.0 | 1×3NG; 5×MLI; 2×IMD; | |||
| Crystal structure of GSK3b in complex with CX-4945 | monomer | 100.0 | 1×3NG; 1×IMD; 2×YT3; | |||
| Crystal Structure of GSK3beta in complex with a Imidazopyridine inhibitor | monomer | 100.0 | 1×0KD; | |||
| 6-Amino-4-(pyrimidin-4-yl)pyridones: Novel Glycogen Synthase Kinase-3 Inhibitors | monomer | 100.0 | 1×55E; | |||
| Glycogen synthase kinase-3 beta in complex with bis-(indole)maleimide pyridinophane inhibitor | monomer | 100.0 | 1×BIM; | |||
| Crystal structure of GSK-3b in complex with the 1H-indazole-3-carboxamide inhibitor 2 | monomer | 100 | 1×OH8; 1×ACT; 2×GOL; | |||
| Glycogen synthase kinase-3 beta (GSK3b) in complex with ligand 1 | monomer | 100 | 1×N1Q; 2×ACT; | |||
| Crystal structure of human glycogen synthase kinase 3 beta (GSK3b) in complex with inhibitor 142 | monomer | 100.0 | 1×OFT; 1×MLA; 1×FMT; | |||
| Crystal structure of GSK-3B in complex with pyrazine inhibitor C44 | monomer | 100 | 1×G8B; 1×MLI; 3×GOL; 1×CL; 1×DMS; | |||
| Crystal structure of human GSK3B in complex with G5 | monomer | 100 | 1×CL; 1×L7I; | |||
| Glycogen Synthase Kinase 3 beta Complexed with BRD0209 | monomer | 100.0 | 1×6VK; | |||
| Crystal structure of GSK-3B in complex with pyrazine inhibitor C22 | monomer | 100 | 1×MLI; 3×GOL; 3×DMS; 1×G8E; | |||
| Crystal structure of human GSK3B in complex with ARN9133 | monomer | 100 | 1×CL; 1×L7R; | |||
| Crystal structure of human GSK3B in complex with ARN1484 | monomer | 100 | 1×CL; 1×L7W; | |||
| Crystal Structure of GSK3beta in complex with a benzoimidazol inhibitor | monomer | 100 | 1×HBM; | |||
| Crystal structure of GSK-3b in complex with the imidazo[1,5-a]pyridine-3-carboxamide inhibitor 16 | monomer | 100.0 | 1×OHK; 2×ACT; | |||
| CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 3-[(CYCLOPROPYLMETHYL)AMINO] -N… | monomer | 100.0 | 1×U6S; | |||
| X-ray Co-Crystal Structure of Glycogen Synthase Kinase 3beta in Complex with an Inhibitor | monomer | 100.0 | 1×34O; | |||
| GSK3beta inhibitor complex | monomer | 100.0 | 1×G3B; | |||
| Glycogen Synthase Kinase 3 beta Complexed with BRD0705 | monomer | 100.0 | 1×6VL; | |||
| glycogen synthase Kinase 3beta inhibitor complex | monomer | 100.0 | 1×3HT; 1×2HT; | |||
| Crystal Structure of Glycogen Synthase Kinase-3 beta in Complex with BI-91BS | monomer | 100 | 1×F1B; | |||
| Co-structure of human glycogen synthase kinase beta with 1-(6-((2-((6-amino-5-nitropyridin-2-yl)ami… | monomer | 100.0 | 1×QQA; 1×PO4; | |||
| Crystal structure of GSK-3 beta in complex with NMS-869553A | monomer | 100.0 | 1×553; | |||
| CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 3-[(CYCLOPROPYLMETHYL)AMINO] -N… | monomer | 100.0 | 1×U3E; | |||
| Crystal structure of human GSK3B in complex with G12 | monomer | 100.0 | 1×L7C; 1×CL; | |||
| Crystal Structure of GSK3b in complex with inhibitor 1R | monomer | 100 | 1×1JX; 2×SO4; 1×CL; | |||
| CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH (4S)-N-{4-[(2S)-2-methylmorphol… | monomer | 100.0 | 1×UAU; | |||
| Crystal structure of GSK3b in complex with Compound 18: 2-[(cyclopropylcarbonyl)amino]-N-(4-phenylp… | monomer | 100.0 | 1×3UP; | |||
| Co-structure of human glycogen synthase kinase beta with a selective (5-imidazol-2-yl-4-phenylpyrim… | monomer | 100.0 | 1×GOL; 1×65C; | |||
| Crystal Structure of Glycogen synthase kinase-3 beta (GSK3B) in Complex with PIK-75 | monomer | 100.0 | 1×CL; 1×F4N; | |||
| Glycogen Synthase Kinase 3 beta Complexed with BRD3731 | monomer | 100.0 | 1×6VM; | |||
| Crystal Structure of GSK3b in complex with inhibitor 15R | monomer | 100.0 | 1×PO4; 1×I5R; 1×K; | |||
| Structure of Glycogen Synthase Kinase 3 beta (GSK3B) in complex with a ruthenium octasporine ligand… | monomer | 100.0 | 1×OS1; | |||
| GSK3-beta in complex with compound (S)-5c | monomer | 100 | 1×SZW; 2×EDO; 2×SO4; | |||
| Crystal structure of GSK-3beta complexed with PF-04802367, a highly selective brain-penetrant kinas… | monomer | 100.0 | 1×6QH; 1×SO4; | |||
| CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 2-[(4-CYANOPHENYL)AMINO]-N-(4-P… | monomer | 100 | 1×XV0; | |||
| Structure of a carboxamine compound (26) (2-{2-[(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}-4-METHOXYP… | monomer | 100.0 | 1×2WG; | |||
| X-RAY CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH BRD3937 | monomer | 100.0 | 1×65A; | |||
| Exploiting an Asp-Glu switch in Glycogen Synthase Kinase 3 to design paralog selective inhibitors f… | monomer | 99.7 | 1×6VL; | |||
| Crystal structure of GSK-3B in complex with pyrazine inhibitor C50 | monomer | 100 | 1×GOL; 1×DMS; 1×G8N; | |||
| Crystal structure of GSK3b in complex with Compound 15: 2-[(cyclopropylcarbonyl)amino]-N-(4-methoxy… | monomer | 100 | 1×3UO; | |||
| Crystal structure of GSK3b in complex with N-(4-(5-(1,2,4-oxadiazol-3-yl)thiophen-2-yl)pyridin-2-yl… | monomer | 100.0 | 1×VNG; | |||
| Gsk-3beta with inhibitor 6-chloro-N-cyclohexyl-4-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyridin-2-amine | monomer | 100.0 | 1×IQ6; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1j1b.1.B | monomer | 0.88 | 1×ANP; | 100.00 | ||
1 SWISS-MODEL model built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 1j1b.1.B | monomer | 0.84 | 1×ANP; | 100.00 | ||